Effect of Short-Term Modified Alternate-Day Fasting on the Lipid Metabolism in Obese Women

سال انتشار: 1390
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 53

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJDO-3-1_001

تاریخ نمایه سازی: 16 آبان 1402

چکیده مقاله:

OBJECTIVE: Obesity is a worldwide health problem, with increasing prevalence associated with an increased risk of chronic diseases. Decrease in energy intake has been shown to lower the risk of coronary artery disease (CAD) in obese. The common form of dietary restriction is daily calorie restriction (CR). Another form is alternate-day fasting (ADF). The ability of modified ADF to facilitate weight loss and lower cardiovascular risk factors has not been tested. This study examined the effects of combination CR and ADF in obese adults. MATERIALS AND METHODS: ۲۶ female obese inpatients completed a ۴ week trial of controlled food intake during modified ADF period. All subjects consumed very low calorie diet on the fast day and then consumed diet including ۱۶۰۰ - ۱۷۰۰ Kcal in every other day. Body weight (BW) and blood pressure (BP) were measured daily. Fasting blood samples were collected at the first and ۲۹th day of trial for biochemical analysis. RESULTS: During the course of the trial (۴ wk), BW of the subjects decreased (P < ۰.۰۰۰۱) from ۹۶.۸۷ ± ۲۱.۳۴ kg to ۹۲.۱۶ ± ۱۹.۸۵ kg. Mean BMI of the subjects at baseline was ۳۷.۳۸ ± ۷.۳۵ kg/m۲, at the end of course decreased (P < ۰.۰۰۰۱) to ۳۵.۵۶ ± ۶.۷۸ kg/m۲. Systolic BP decreased (P < ۰.۰۰۰۱) from ۱۴۲ ± ۱۳ to ۱۲۲ ± ۱۲mm Hg. Total cholesterol decreased (P < ۰.۰۰۰۱) from ۶.۱۲ ± ۱.۱ to ۵.۴۲ ± ۱ mmol/L , LDL (P <۰.۰۰۰۱) from ۳.۹۹ ± ۰.۹۶ to ۳.۳۴ ± ۰.۸۷ mmol/L, fasting blood sugar (P < ۰.۰۰۰۱) from ۵.۸۷ ± ۱ to ۵.۲۳ ± ۰.۹ mmol/L, whereas change in triacylglycerol concentrations was not significant, HDL decreased (P < ۰.۰۰۵) from ۱.۴۳ ± ۰.۳۸ to ۱.۳ ± ۰.۳۱ mmol/L . CONCLUSION: These findings suggest that short time CR plus ADF is a viable dietary option to help obese individuals lose weight and decrease systemic blood pressure and some CAD risk factors. More and longer-term studies in human subjects are needed to support this important result.